These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 452467)

  • 1. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
    Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
    Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
    [No Abstract]   [Full Text] [Related]  

  • 2. [Certain debatable questions concerning the use of nonachlazine in patients with chronic ischemic heart disease].
    Iagus KhK
    Ter Arkh; 1980; 52(9):97-101. PubMed ID: 7434242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nonachlazine on the echocardiographic parameters in patients with post-infarct cardiosclerosis].
    Iagus KhK
    Ter Arkh; 1980; 52(5):42-6. PubMed ID: 7404363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of nonachlazine in ischemic heart disease under ambulatory conditions].
    Glezer GA; Shraĭber NM; Pak GP; Moskalenko NP
    Kardiologiia; 1980 Jul; 20(7):53-6. PubMed ID: 7401440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of nonachlazine on the creatine phosphokinase and acid phosphatase activity and on the lysosomal membrane stability of the ischemic myocardium in rats after preliminary reserpinization].
    Sysoliatina NA
    Farmakol Toksikol; 1986; 49(4):77-81. PubMed ID: 3758337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibility of the pharmacologic treatment of post-ischemic myocardial damage].
    Rozonov IuB; Morozova TV; Markin VA; Pokazeeva ZT
    Biull Eksp Biol Med; 1986 Sep; 102(9):301-3. PubMed ID: 3756329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia].
    Chichkanov GG; Bogolepov AK
    Biull Eksp Biol Med; 1978 Dec; 86(12):691-4. PubMed ID: 728611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nonachlazine on ATP, ADP, and lactic acid concentration in intact and ischemic myocardium].
    Turilova AI; Azvolinskaia TN; Kryzhanovskiĭ SA
    Biull Eksp Biol Med; 1980 Jul; 89(7):49-51. PubMed ID: 7407371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of nonachlazine and ethmozine on the cardiac blood supply in acute myocardial ischemia].
    Pilipchuk DB
    Farmakol Toksikol; 1981; 44(1):63-7. PubMed ID: 7021174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
    Pilipchuk DB; Berger DIa; Sapozhkov AV
    Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of adrenergic beta 1 receptor agonists in the correction of hemodynamics in patients with chronic cor pulmonale].
    Gavrisiuk VK; Morskaia ND; Iachnik AI; Morozova NA; Iakhnitsa TV
    Klin Med (Mosk); 1990 Jan; 68(1):60-3. PubMed ID: 2186208
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peripheral vasodilators and beta-stimulants in the treatment of the initial stages of chronic circulatory insufficiency].
    Shevchenko VA
    Vrach Delo; 1987 Sep; (9):15-8. PubMed ID: 3424762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nonachlazine in solution as an arresting agent in stenocardiac attacks].
    Boĭko SS; Kaverina NV; Liubimov BI; Markova GA; Mitrofanov VS
    Farmakol Toksikol; 1979; 42(3):243-7. PubMed ID: 446702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nonachlazine on the energy provision for cardiac contractile activity in experimental myocardial infarct].
    Reznikov KM; Provotorova PP; Sidel'nikova VI
    Farmakol Toksikol; 1982; 45(5):52-7. PubMed ID: 7140956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological and clinical study of the liquid drug form of nonachlazine].
    Kniazev MD; Kaverina NV; Aslibekian IS; Kirichenko AA; Vorovkov AI
    Kardiologiia; 1979 Oct; 19(10):14-7. PubMed ID: 502162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of computers for detecting the dynamics of changes in the cardiac adaptation reserves of alcoholism patients treated with nonachlazine].
    Kaverina NV; Berdiaev SIu; Mel'nikova TS
    Biull Eksp Biol Med; 1982 May; 93(5):68-72. PubMed ID: 7046840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.